If you want to distinguish your goods, services or both from those of another company, you may need a trademark or trade name. Find out what they are, what their registration procedure is and what it involves.
Information on the deadlines for filing applications for transformation of European Union trademarks into Spanish national trademarks. See more
If you have a new device, product or procedure that solves a technical problem or has a practical advantage, there are different ways to protect it in Spain and other countries. Find out how.
Does your innovation lie in the aesthetics, ornamentation or appearance of your product? Protect it through industrial design. Find out what rights registration confers and how to proceed.
Geographical indications protect the name of a product that has a specific geographical origin and owes its qualities, characteristics or reputation to its particular origin. Find out what they are, how the registration process works and what benefits they provide.
Patents published worldwide are a valuable source of scientific, technical and commercial information.
El Bono 3 del Fondo para PYMEs 2025, que cubre la elaboración de Informes Tecnológicos de Patentes (ITP) y Búsquedas Retrospectivas se cerrará el lunes 10 de febrero de 2025 al cierre de la jornada laboral. Próximamente se informará sobre su reapertura. Puede consultar más información aquí.
If you are an entrepreneur or a company and you want to boost and improve the profitability of your business by adequately protecting the intangible assets of your organisation, in this space you will find what you need.
415
results.
Updated on
14/07/2026 [08:01:00]
Results 25 to 50 of 415
Absstract of: US20260191435A1
0000 Glucose level measurements of a user are obtained over time, such as from a wearable glucose monitoring device being worn by the user. These glucose level measurements can be produced substantially continuously, such that the device may be configured to produce the glucose level measurements at regular or irregular intervals of time, responsive to establishing a communicative coupling with a different device, and so forth. These glucose level measurements are analyzed to detect deviations from past glucose measurements, such as glucose measurements received earlier in the day or glucose measurements received at corresponding times of one or more preceding days. Indications of detected deviations are provided to the user or communicated elsewhere, such as to a healthcare professional.
Absstract of: US20260191629A1
0000 A consumable extrusion control system, a consumable extrusion control method and a consumable extrusion control device are provided. The consumable extrusion control system includes: a main body; a plurality consumable chambers coupled to the main body through respective pipelines; a plurality of first driving assemblies arranged on the respective pipelines for the consumable chambers, and configured to provide a driving force for consumables in the consumable chambers; and a control unit arranged at the main body, and configured to control and switch a corresponding first driving assembly to operate, to deliver the consumable from a corresponding one of the consumable chambers to the main body.
Absstract of: US20260191595A1
Systems and methods for designing and implementing patient-specific surgical procedures and/or medical devices are disclosed. In some embodiments, a method includes receiving intra-operative data during a surgical procedure to install a patient-specific implant in a patient. The system can compare the intra-operative data to a pre-operative plan to determine whether the implant is positioned and located according to the pre-operative plan.
Absstract of: US20260192047A1
0000 An infusion device includes a display and a pump configured for a predetermined volume per mechanical revolution (“VPMR”) under default environmental conditions. The infusion device receives infusion parameters that include (1) a requested flow rate of a fluid to be infused by the infusion device and, and (2) a head height and/or a patient height. The infusion device determines deviated environmental condition values as a function of (1) the received infusion parameters and (2) the default environmental conditions. The infusion device also determines a flow rate accuracy metric as a function of (1) the deviated environmental condition values and (2) an expected performance metric under the default environmental conditions. Responsive to determining the flow rate accuracy metric, the infusion device (a) displays, via the display, an indication of the flow rate accuracy metric; or (b) adjusts an operating speed of the pump based on the flow rate accuracy metric.
Absstract of: US20260196348A1
Provided herein are methods of training a model to detect cardiovascular disease in a subject from portable electrocardiogram (ECG) signal data and computer-implemented methods of detecting cardiovascular disease in a subject. The methods of training a model includes selecting an ECG dataset corresponding to a cardiovascular disease, the ECG dataset including multiple distinct ECGs, forming a training dataset from the ECG dataset, training the nodes of a deep neural network on the training dataset, and including random gaussian noise with each ECG of the ECG dataset during the training of the nodes. The computer-implemented methods of detecting cardiovascular disease in a subject include applying a deep neural network to ECG data for a subject, the deep neural network being trained according to the training methods disclosed herein.
Absstract of: US20260192299A1
Improved sample container embodiments are provided for containing and supporting tissue samples during imaging. These sample containers support the samples to prevent distortion due to gravity and/or forces applied on the sample by elements of the container itself. Images generated for the samples thus more accurately reflects the geometry, composition, and orientation of the samples in the body prior to their removal. Such sample containers can include compliant cushions, which may be formed from sheets of material rather than solid volumes of foam or other materials. Such a reduction in cushion material proximate to the sample can result in improved sample imaging. The sample container can also be composed of fluid-impermeable materials to prevent absorption of fluid from the sample, reducing sample deformation and also reducing the imaging of the container material due to absorption of fluid from the sample.
Absstract of: US20260193576A1
0000 The invention relates to a cleaning solution for cleaning an object produced using a 3D printing method, to a method for cleaning an object produced using a 3D printing method by means of the cleaning solution according to the invention, and to the use of the cleaning solution according to the invention to clean an object produced using a 3D printing method. The cleaning solution according to the invention comprises a carbonate and water.
Absstract of: US20260191896A1
Some embodiments provide for a method for identifying an intervention for a subject in furtherance of preventing development of cardiovascular disease in the subject, the method comprising: obtaining cardiometabolic health data for the subject; determining, using at least some of the cardiometabolic health data, a first trained machine learning (ML) model and for each of multiple time intervals, one or more measures of risk that the subject develops cardiovascular disease to obtain multiple measures of risk; determining, using the multiple measures of risk that the subject develops cardiovascular disease and at least one second trained ML model, benefit of administering to the subject one or more therapeutic interventions designed to reduce risk of cardiovascular disease by targeting one or more modifiable causes of the cardiovascular disease; and identifying, using the determined benefit of administering the therapeutic intervention(s), at least one therapeutic intervention to recommend being administered to the subject.
Absstract of: US20260191471A1
0000 A system and method to confirm the insertion of an analyte-selective sensor comprising an array of microneedles possessing vertical extent between 200 and 2000 μm into viable tissue is disclosed herein. Mechanical insertion of an analyte-selective sensor is firstly attempted by means of an application of external force. Either during or following this routine, an electrical stimulus is applied between at least two distinct electrodes located within the said analyte-selective sensor; a resultant response is measured. This response is compared with a reference value to determine if insertion was successful. If insertion was successful, no further effort is required and the sensor can operate as intended. However, if insertion was not successful, the user can be instructed to continue to apply additional force to said sensor to achieve successful insertion or otherwise re-apply the said sensor altogether.
Absstract of: US20260192078A1
0000 Provided herein is a system for treating chronic pain in a patient, the system including a user computing device including a display screen and a brain-computer interface (BCI) device communicatively coupled to the user computing device. The BCI device includes a processor communicatively coupled to an EEG headset and a vibrotactile device. The processor is configured to (i) prompt, through a display screen, the patient to carry out a plurality of cognitive tasks, the plurality of cognitive tasks selected to create theta activation brainwaves in the patient, (ii) monitor progress of the patient toward reaching a predetermined theta activation goal, (iii) display, through the display screen, a visual feedback via a cue, such as a goal bar, showing the progress of the patient in relation to the predetermined theta activation goal, and (iv) activate, in response to the patient reaching the predetermined theta activation goal, the vibrotactile device to generate multi-modal sensory feedback.
Absstract of: US20260191565A1
0000 A load-carrying rod for an implant system has a structure of individual interconnected solidified droplets so that the transitions from one droplet to another act as crack stoppers in the event of a crack.
Absstract of: US20260196350A1
The disclosed systems and methods provide systems and methods for rhythm recognition and the analysis of ECG signals.
Absstract of: AU2024395288A1
Certain aspects of the present disclosure relate to methods and systems for distinguishing between temporary compression of a sensor of a continuous analyte monitoring system and failure of the sensor, such as due to detachment of the sensor. In certain aspects, an apparatus includes an analyte sensor, a temperature sensor, a memory, and a processor communicatively coupled to the memory. The processor is configured to evaluate samples of an output of the analyte sensor and samples of an output of the temperature sensor with respect to a threshold condition. If the threshold condition is met, the processor is configured to generate a signal indicating failure of the analyte sensor.
Absstract of: US20260196330A1
0000 Methods and systems for planning a trajectory for implanting electrical stimulation leads in a patient's brain are described. The methods and systems rank candidate trajectories based on their expected therapeutic efficacies, as well as other criteria. Optimized stimulation parameters are determined for each of the candidate trajectories and therapeutic efficacies using the optimized parameters are predicted.
Absstract of: US20260195933A1
0000 Described herein are devices for processing surgical video data associated with a surgery and methods of operating the same. An exemplary device includes a housing and a programmable circuit that is enclosed in the housing and configured to receive the surgical video data from a camera control unit. A processor is enclosed in the housing. The processor is communicatively coupled with the programmable circuit and is configured to execute a plurality of instructions for processing the video data stored on a memory. A galvanically isolated connector is exposed on the housing. The galvanically isolated connector is configured to be connected to a surgical device for contact with a patient during the surgery.
Absstract of: WO2026146775A1
The present invention relates to a 3D printing resin composition for a transparent aligner, a method for preparing same, and a transparent aligner formed by 3D printing using same, the composition comprising 5-20 wt% UDMA (urethane dimethacrylate), 40-70 wt% BIS-GMA (bisphenol A-glycidyl methacrylate), 8-30 wt% BIS-EMA (ethoxylated bisphenol A dimethacrylate), 2-5 wt% TEGDMA (triethylene glycol dimethacrylate), 8-9 wt% modified PVA powder, 5-9 wt% of a filler, 0.72-3.7 wt% of a curing agent, and 0.1-1.0 wt% of an additive, wherein the transparent aligner can be modified to have a structure optimized for the oral cavities of individual users, and thus can maximize the aligning effect.
Absstract of: DE112023006984T5
Computerimplementiertes Verfahren zur Bereitstellung von Anzeigedaten für ein halbtransparentes Durchsichtanzeigegerät in einer medizinischen Umgebung, wobei das Verfahren die Schritte umfasst: Bereitstellen eines 2D- und/oder 3D-Modells eines ersten Objekts (Schritt S1); Empfangen von ersten Positionsdaten des ersten Objekts (Schritt S2); Empfangen von zweiten Positionsdaten eines zweiten Objekts (Schritt S3); Erfassen eines Freiraums basierend auf den zweiten Positionsdaten (Schritt S4); Bestimmen von Anzeigedaten zur Anzeige auf einem halbtransparenten Durchsichtanzeigegerät basierend auf dem 2D- und/oder 3D-Modell, dem erfassten Freiraum, den ersten Positionsdaten und den zweiten Positionsdaten (Schritt S5); und Bereitstellen der bestimmten Anzeigedaten zur Anzeige auf dem halbtransparenten Durchsichtanzeigegerät (Schritt S6).
Absstract of: US20260192061A1
An inhalation device includes a housing defining an air flow channel, a pressure sensor configured to detect air flow within the air flow channel, and a piezoelectric driven ejector configured to eject droplets of a fluid into the air flow channel. A controller is electrically coupled to the pressure sensor and the piezoelectric driven ejector. During an initialization phase in which a user takes a set number of deep breaths, the controller determines a trigger point based on measured inhalation flow. The pressure sensor generates a peak inspiratory flow measurement based on a minimum pressure during inhalation and a pulmonary output based on a maximum flow achieved during exhalation. During a dosing inhalation, the controller actuates the piezoelectric driven ejector when the trigger point is reached to dispense a dose of the fluid. The device may further generate pulmonary health management information based on inspiratory and expiratory flow measurements.
Absstract of: US20260192043A1
0000 Systems and methods are provided relating to open loop decision-making for management of diabetes. People with diabetes face many problems in controlling their glucose because of the complex interactions between food, insulin, exercise, stress, activity, and other physiological and environmental conditions. Established principles of management of glucose sometimes are not adequate because there is a significant amount of variability in how different conditions impact different individuals and what actions might be effective for them. Accordingly, systems and methods according to present principles minimize the impact of the vagaries of diabetes on individuals, i.e., by looking for patterns and tendencies of an individual and customizing the management to that individual. Consequently, the same reduces the uncertainty that diabetes typically is associated with and improves quality of life.
Absstract of: US20260191659A1
Various methods for making an implant for interfacing with a bone structure are described. The implant includes a web structure having a space truss. The implant may be made according to a three-dimensional model of the implant. The implant may be made by applying multiple layers of a biocompatible material to a support (e.g., a support structure) in a layer-by-layer process. The web structure may have a plurality of struts joined at nodes where the web structure is configured to interface with human bone tissue.
Absstract of: US20260191434A1
Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.
Absstract of: US20260191771A1
Disclosed herein are contraceptive medical devices that include at least a polymeric ring, a porous barrier material and an injection molding guide, where the guide may be symmetrical and/or have one or a plurality of planar surfaces, where the device may optionally administer at least one active agent.
Absstract of: US20260196324A1
Methods and systems relate to providing varying levels of detail about a pharmacy item to a patient information system based on the capabilities of the patient information system. An intercept device can receive an identifier associated with a pharmacy item based on a scanner reading a computer-readable code. The intercept device can recognize or determine the storage capabilities or limitations of the patient information system, for example by determining various medication data fields that the patient information system uses to store pharmacy item information. The intercept device can use the machine readable code to obtain pharmacy item information that is compatible with the patient information system based on those storage capabilities or limitations and can distribute that pharmacy item information to the patient information system.
Absstract of: US20260193617A1
0000 Disclosed herein are organoid compositions that are manipulated to form shaped or elongated morphologies that more closely resemble native organ structures. These shaped organoids are advantageous for purposes such as studying organellar organization and for transplants compared to unformed organoids. Also disclosed herein are methods of producing said shaped or elongated organoid compositions.
Nº publicación: US20260192017A1 09/07/2026
Applicant:
AKIRA SCIENCE AB [SE]
Akira Science AB
Absstract of: US20260192017A1
0000 The present disclosure is directed to a degradable 3D-printable scaffold for use in tissue engineering, which scaffold has a combined gradient and staggered structure. Further provided is a medical device for use in tissue engineering, comprising such a scaffold. The present disclosure also provides a method for preparing a scaffold by additive manufacturing, e.g. 3D-printing, a method for in vivo tissue engineering, use of the scaffold in an in vitro cell culture system, in an in vitro method for culturing of cells and/or in an in vitro method for regenerating tissue. Also provided is a scaffold and a medical device for use in a method for in vivo tissue engineering. Further disclosed is a novel degradable copolymer of ε-caprolactone and p-dioxanone, which can be printed without degradation and which is particularly suitable for use as scaffold material in the scaffold and method according to the present disclosure.
BOPI
Electronic site
